Author: Kato Y. Tsuda T. Hosaka Y. Takahashi T. Shirakawa K. Furusako S. Mizuguchi K. Mochizuki H.
Publisher: Elsevier
ISSN: 0014-2999
Source: European Journal of Pharmacology, Vol.428, Iss.3, 2001-10, pp. : 371-379
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Ocak Guzide Ayse Ozbilim Gulay Delibas Namik Gumuslu Saadet
Canadian Journal of Physiology and Pharmacology, Vol. 91, Iss. 9, 2013-01 ,pp. :
The vulnerable atherosclerotic plaque
Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. :
Agents that stabilise atherosclerotic plaque
Expert Opinion on Investigational Drugs, Vol. 12, Iss. 10, 2003-10 ,pp. :
Atorvastatin induces atherosclerotic plaque regression
Inpharma, Vol. 1, Iss. 1484, 2005-01 ,pp. :